Cover Image
市場調查報告書

慢性腎臟病(慢性腎衰竭):全球臨床實驗趨勢

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 201072
出版日期 內容資訊 英文 1023 Pages
訂單完成後即時交付
價格
Back to Top
慢性腎臟病(慢性腎衰竭):全球臨床實驗趨勢 Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015
出版日期: 2015年10月30日 內容資訊: 英文 1023 Pages
簡介

本報告提供慢性腎臟病(慢性腎衰竭)相關臨床研究最新趨勢分析、疾病與治療方法概要,及G7及E7各國的臨床實驗狀況、各地區、各階段的進行狀況、有潛力的贊助商、各企業及研究機關的研究進行狀況、有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

簡介

  • 慢性腎臟病(慢性腎衰竭)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 慢性腎臟病(慢性腎衰竭)臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量: G7各國

G7各國的臨床實驗數量:各相位

E7各國的臨床實驗數量: 慢性腎臟病(慢性腎衰竭)臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量: E7各國

E7各國的臨床實驗數量:各相位

各相位臨床實驗數量

  • 各相位的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

未完成的臨床實驗 慢性腎臟病(慢性腎衰竭)

一定期間中採用的實驗人數

贊助商的各種類的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 慢性腎臟病(慢性腎衰竭)治療藥

有潛力的藥劑

  • 最新臨床實驗新聞: 慢性腎臟病(慢性腎衰竭)

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Amgen Inc.
    • Sanofi
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Novartis AG
    • Pfizer Inc.
    • Shire Plc
    • Astellas Pharma Inc.
    • Abbott Laboratories
    • AstraZeneca Plc
  • 代表性研究機關/醫院臨床實驗概要
    • Shiraz University of Medical Sciences
    • Isfahan University of Medical Sciences
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Vanderbilt University
    • The National Institute of Allergy and Infectious Diseases
    • Seoul National University Hospital
    • Tabriz University of Medical Sciences
    • Tehran University of Medical Sciences
    • University of Michigan
    • Aarhus University

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2919CTIDB

GlobalData's clinical trial report, "Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials 31
  • Prominent Drugs 33
  • Latest Clinical Trials News on Chronic Kidney Disease (Chronic Renal Failure) 34
  • Oct 06, 2015: Akebia Reaches Agreement with FDA and EMA on Vadadustat Global Phase 3 Program 34
  • Oct 05, 2015: Results from Merck's Phase 3 Study of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir in Patients with Advanced Chronic Kidney Disease Published in The Lancet 34
  • Oct 05, 2015: Atara Bio's Collaborating Investigators to Present Data at the American Society of Nephrology Kidney Week 2015 35
  • Sep 08, 2015: Akebia Announces Positive Top-Line Results from its Phase 2 Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease 35
  • Aug 04, 2015: International Clinical Steering Committee Announced for Resverlogix's Phase 3 BETonMACE Clinical Trial with RVX-208 "apabetalone" 36
  • Clinical Trial Profile Snapshots 38

Appendix 1020

  • Abbreviations 1020
  • Definitions 1020
  • Research Methodology 1021
  • Secondary Research 1021
  • About GlobalData 1022
  • Contact Us 1022
  • Disclaimer 1022
  • Source 1023

List of Tables

  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region, 2015* 6
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
  • Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
  • Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 20
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase, 2015* 23
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

List of Figures

  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
  • Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
  • Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 19
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
  • Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
  • GlobalData Methodology 1021
Back to Top